KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTCIQ: KRTL), is a research and development company with operations in the US, Korea, and forming collaborations in other countries. With a collective of experienced Korean, and US doctors and researchers dedicated to improving mankind’s debilitating mental ailments with progressive pre-formulations created through our partnerships. KRTL Biotech’s doctors and researchers are disciplined in the CBD and Psilocybin arena and will study and work with these and other plant-based products.